Search Page

1

Cite

Share

Opiates as antidepressants.

Berrocoso E, Sánchez-Blázquez P, Garzón J, Mico JA. Berrocoso E, et al. Among authors: sanchez blazquez p. Curr Pharm Des. 2009;15(14):1612-22. doi: 10.2174/138161209788168100. Curr Pharm Des. 2009. PMID: 19442177 Review.

Cite

Share

2

Cite

Share

Effects of Gαi₂ and Gαz protein knockdown on alpha_2A-adrenergic and cannabinoid CB₁ receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex.

Ramos-Miguel A, Sánchez-Blázquez P, García-Sevilla JA. Ramos-Miguel A, et al. Among authors: sanchez blazquez p. Pharmacol Rep. 2021 Aug;73(4):1122-1135. doi: 10.1007/s43440-021-00240-4. Epub 2021 Feb 28. Pharmacol Rep. 2021. PMID: 33641090

Cite

Share

3

Cite

Share

Mediterranean spotted fever with encephalitis.

Aliaga L, Sánchez-Blázquez P, Rodríguez-Granger J, Sampedro A, Orozco M, Pastor J. Aliaga L, et al. Among authors: sanchez blazquez p. J Med Microbiol. 2009 Apr;58(Pt 4):521-525. doi: 10.1099/jmm.0.004465-0. J Med Microbiol. 2009. PMID: 19273650 Review.

Cite

Share

4

Cite

Share

Human HINT1 Mutant Proteins that Cause Axonal Motor Neuropathy Exhibit Anomalous Interactions with Partner Proteins.

Cortés-Montero E, Rodríguez-Muñoz M, Sánchez-Blázquez P, Garzón-Niño J. Cortés-Montero E, et al. Among authors: sanchez blazquez p. Mol Neurobiol. 2021 Apr;58(4):1834-1845. doi: 10.1007/s12035-020-02265-x. Epub 2021 Jan 6. Mol Neurobiol. 2021. PMID: 33404983

Cite

Share

5

Cite

Share

Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.

Rodríguez-Muñoz M, Sánchez-Blázquez P, Merlos M, Garzón-Niño J. Rodríguez-Muñoz M, et al. Among authors: sanchez blazquez p. Oncotarget. 2016 Aug 23;7(34):55840-55862. doi: 10.18632/oncotarget.10095. Oncotarget. 2016. PMID: 27323834 Free PMC article. Review.

Cite

Share

6

Cite

Share

The σ1 Receptor and the HINT1 Protein Control α2δ1 Binding to Glutamate NMDA Receptors: Implications in Neuropathic Pain.

Rodríguez-Muñoz M, Cortés-Montero E, Onetti Y, Sánchez-Blázquez P, Garzón-Niño J. Rodríguez-Muñoz M, et al. Among authors: sanchez blazquez p. Biomolecules. 2021 Nov 12;11(11):1681. doi: 10.3390/biom11111681. Biomolecules. 2021. PMID: 34827679 Free PMC article.

Cite

Share

7

Cite

Share

Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.

Garzón J, Rodríguez-Muñoz M, Sánchez-Blázquez P. Garzón J, et al. Among authors: sanchez blazquez p. Curr Drug Abuse Rev. 2012 Sep;5(3):199-226. doi: 10.2174/1874473711205030199. Curr Drug Abuse Rev. 2012. PMID: 22920535 Review.

Cite

Share

8

Cite

Share

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception.

Sánchez-Blázquez P, Cortés-Montero E, Rodríguez-Muñoz M, Merlos M, Garzón-Niño J. Sánchez-Blázquez P, et al. Mol Brain. 2020 Nov 11;13(1):150. doi: 10.1186/s13041-020-00676-4. Mol Brain. 2020. PMID: 33176836 Free PMC article.

Cite

Share

9

Cite

Share

Schizophrenia and depression, two poles of endocannabinoid system deregulation.

Rodríguez-Muñoz M, Sánchez-Blázquez P, Callado LF, Meana JJ, Garzón-Niño J. Rodríguez-Muñoz M, et al. Among authors: sanchez blazquez p. Transl Psychiatry. 2017 Dec 18;7(12):1291. doi: 10.1038/s41398-017-0029-y. Transl Psychiatry. 2017. PMID: 29249810 Free PMC article.

Cite

Share

10

Cite

Share

The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.

Sánchez-Blázquez P, Rodríguez-Muñoz M, Garzón J. Sánchez-Blázquez P, et al. Front Pharmacol. 2014 Jan 2;4:169. doi: 10.3389/fphar.2013.00169. Front Pharmacol. 2014. PMID: 24427139 Free PMC article. Review.

Cite

Share